Organization: Health Canada
Year: 2024
Month: September
Request Number: A-2024-000256
Request Summary: The labels for all package types for all strengths or combinations of strengths of the final dosage forms which were included in the initial filing of the Abbreviated New Drug Submission (ANDS) for Tolvaptan from which was accepted into review in November 2023 and was included in the list of Generic submissions under review dated 2024-05-23.
Disposition: Disclosed in part
Number of pages: 17